Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 11 | 2021 | 16 | 5.760 |
Why?
|
| Receptors, Progesterone | 6 | 2021 | 12 | 3.070 |
Why?
|
| Estrogen Receptor alpha | 6 | 2018 | 22 | 1.580 |
Why?
|
| Epithelial Cells | 4 | 2021 | 31 | 1.470 |
Why?
|
| Papillomavirus E7 Proteins | 4 | 2021 | 5 | 1.350 |
Why?
|
| Medroxyprogesterone Acetate | 3 | 2019 | 3 | 1.260 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2019 | 2 | 1.200 |
Why?
|
| Mice | 12 | 2023 | 719 | 1.090 |
Why?
|
| Estrogens | 4 | 2021 | 21 | 1.030 |
Why?
|
| Cell Proliferation | 5 | 2021 | 120 | 1.010 |
Why?
|
| Mice, Transgenic | 8 | 2021 | 50 | 0.990 |
Why?
|
| Oncogene Proteins, Viral | 3 | 2021 | 4 | 0.970 |
Why?
|
| Animals | 13 | 2023 | 1817 | 0.960 |
Why?
|
| Female | 13 | 2021 | 2811 | 0.870 |
Why?
|
| Cervix Uteri | 3 | 2021 | 7 | 0.780 |
Why?
|
| Progestins | 1 | 2021 | 1 | 0.730 |
Why?
|
| Neoplasms, Experimental | 1 | 2021 | 5 | 0.730 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 18 | 0.720 |
Why?
|
| Human papillomavirus 16 | 1 | 2021 | 2 | 0.700 |
Why?
|
| Thyroid Hormones | 1 | 2021 | 3 | 0.700 |
Why?
|
| Carrier Proteins | 1 | 2021 | 25 | 0.680 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 7 | 0.680 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2019 | 14 | 0.670 |
Why?
|
| Estradiol | 2 | 2018 | 16 | 0.670 |
Why?
|
| Membrane Proteins | 1 | 2021 | 49 | 0.660 |
Why?
|
| Papillomaviridae | 1 | 2019 | 1 | 0.640 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 7 | 0.630 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2017 | 13 | 0.620 |
Why?
|
| Uterus | 2 | 2016 | 11 | 0.590 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2018 | 12 | 0.560 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 242 | 0.520 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 23 | 0.510 |
Why?
|
| Vagina | 1 | 2016 | 14 | 0.490 |
Why?
|
| Signal Transduction | 2 | 2018 | 225 | 0.480 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 23 | 0.440 |
Why?
|
| Humans | 8 | 2021 | 5477 | 0.420 |
Why?
|
| Hyperplasia | 1 | 2013 | 4 | 0.420 |
Why?
|
| Carcinogenesis | 1 | 2013 | 9 | 0.410 |
Why?
|
| Progesterone | 1 | 2013 | 4 | 0.410 |
Why?
|
| Cell Differentiation | 4 | 2023 | 75 | 0.400 |
Why?
|
| Repressor Proteins | 2 | 2018 | 14 | 0.270 |
Why?
|
| Epithelium | 3 | 2016 | 9 | 0.250 |
Why?
|
| Stromal Cells | 2 | 2018 | 6 | 0.250 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2023 | 10 | 0.210 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 1 | 0.180 |
Why?
|
| Gene Deletion | 1 | 2021 | 15 | 0.180 |
Why?
|
| Phosphorylation | 1 | 2021 | 50 | 0.170 |
Why?
|
| Male | 2 | 2021 | 2765 | 0.170 |
Why?
|
| Gene Expression | 1 | 2021 | 52 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 2 | 2018 | 27 | 0.170 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 175 | 0.160 |
Why?
|
| Mice, Inbred CBA | 1 | 2019 | 1 | 0.160 |
Why?
|
| Keratin-14 | 1 | 2018 | 1 | 0.140 |
Why?
|
| Ovariectomy | 1 | 2018 | 4 | 0.140 |
Why?
|
| Wnt Proteins | 1 | 2018 | 9 | 0.140 |
Why?
|
| Mice, Knockout | 1 | 2018 | 143 | 0.130 |
Why?
|
| Tumor Burden | 1 | 2017 | 3 | 0.130 |
Why?
|
| Treatment Failure | 1 | 2017 | 7 | 0.130 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2014 | 2 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 3 | 0.100 |
Why?
|
| Response Elements | 1 | 2013 | 2 | 0.100 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2013 | 3 | 0.100 |
Why?
|
| Mucins | 1 | 2013 | 4 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 6 | 0.100 |
Why?
|
| Mammary Glands, Animal | 1 | 2013 | 5 | 0.100 |
Why?
|
| Tamoxifen | 1 | 2013 | 12 | 0.100 |
Why?
|
| Mitochondria | 1 | 2013 | 23 | 0.100 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2023 | 3 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2023 | 9 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2023 | 5 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 195 | 0.050 |
Why?
|
| Genitalia, Female | 1 | 2014 | 2 | 0.030 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2014 | 5 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 19 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 59 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 1 | 0.030 |
Why?
|
| High Mobility Group Proteins | 1 | 2013 | 1 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 2013 | 2 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2013 | 11 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 12 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 30 | 0.030 |
Why?
|
| Protein Binding | 1 | 2013 | 118 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 212 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2013 | 69 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 77 | 0.020 |
Why?
|